BIOMAT Database Logo BIOMAT Database Logo

Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer. 2007

Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
College of Pharmacy, Seoul National University, San 56-1, Shilim, Kwanak, Seoul 151-742, Korea.

alpha-GalCer is the first defined and most potent agonistic antigen of the T cell receptor of natural killer T cells. We have prepared a series of 1,2,3-triazole-containing alpha-GalCer analogues in which the lipid chain lengths have been incrementally varied. We found that this isosteric replacement of alpha-GalCer's amide moiety with triazole increases the IL-4 versus IFN-gamma bias of released cytokines. The stimulatory effect was influenced by the length of the attached chain. In particular, the long-chained triazole analogues have a comparable stimulatory effect on cytokine production as alpha-GalCer and exhibit a stronger Th2 cytokine response.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D005699 Galactosylceramides Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy. Galactocerebrosides,Galactosyl Ceramide,Galactosyl Ceramides,Galactosylceramide,Ceramide, Galactosyl,Ceramides, Galactosyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
February 2009, Bioorganic & medicinal chemistry letters,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis and evaluation of amino-modified alpha-GalCer analogues.
July 2010, Organic letters,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Design, Synthesis, and Immunological Evaluation of Benzyloxyalkyl-Substituted 1,2,3-Triazolyl α-GalCer Analogues.
February 2016, ACS medicinal chemistry letters,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment.
October 2013, Archives of pharmacal research,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against Mycobacterium tuberculosis.
August 2023, RSC medicinal chemistry,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis of Pharmacological Relevant 1,2,3-Triazole and Its Analogues-A Review.
January 2021, Current organic synthesis,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis and Antioxidant Properties of Novel 1,2,3-Triazole-Containing Nitrones.
December 2022, Antioxidants (Basel, Switzerland),
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands.
December 2012, Bioorganic & medicinal chemistry,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis and antiplasmodial evaluation of 1H-1,2,3-triazole grafted 4-aminoquinoline-benzoxaborole hybrids and benzoxaborole analogues.
April 2021, Bioorganic chemistry,
Taeho Lee, and Minjae Cho, and Sung-Youl Ko, and Hyun-Jun Youn, and Dong Jae Baek, and Won-Jea Cho, and Chang-Yuil Kang, and Sanghee Kim
Synthesis and in vitro evaluation of alpha-GalCer epimers.
July 2008, ChemMedChem,
Copied contents to your clipboard!